Search Results - I Spicka

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Optimizing the model of heating the material in the reheating furnace in metallurgy by I. Špička, M. Heger, O. Zimný, Z. Jančíková, T. Tykva

    Published in Metalurgija (2016-10-01)
    Get full text
    Article


  2. 2

    Contribution to the thermal properties of selected steels by P. Jonšta, I. Vlčková, L’. Krišták, I. Špička, Z. Jonšta

    Published in Metalurgija (2015-01-01)
    Get full text
    Article


  3. 3

    LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY by E Crusoe, T Facon, P Moreau, I Spicka, K Suzuki, K Yong, J Mikhael, T Fukao, N Armstrong, T Martin

    Published in Hematology, Transfusion and Cell Therapy (2023-10-01)
    Get full text
    Article


  4. 4

    Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-lab... by M. Turgut, P. Moreau, M. Dimopoulos, J. Mikhael, K. Yong, M. Capra, T. Facon, R. Hajek, I. Spicka, M. Risse, G. Asset, S. Macé, T. Martin

    Published in Hematology, Transfusion and Cell Therapy (2020-10-01)
    Get full text
    Article


  5. 5

    P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG... by M Mateos, M Szarejko, J Bila, F Schjesvold, I Spicka, V Maisnar, A Jurczyszyn, Z Grudeva-Popova, R Hajek, G Usenko, M Thuresson, S Norin, S Jarefors, P Richardson, L Pour

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  6. 6

    P967: TUMOR BURDEN AS A CRITICAL PROGNOSTIC FACTOR OF PRIMARY EXTRAMEDULLARY DISEASE by M. Vlachová, M. Štork, S. Ševčíková, T. Jelínek, J. Minařík, J. Radocha, P. Krhovská, L. Pospíšilová, I. Špička, J. Straub, P. Pavlíček, A. Jungová, V. Sandecká, V. Maisnar, R. Hájek, L. Pour

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE... by P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  8. 8

    DP111 | POSITRON EMISSION TOMOGRAPHY WITH COMPUTED TOMOGRAPHY AND MINIMAL RESIDUAL DISEASE FOR EFFICACY ASSESSMENT IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: IMROZ... by E. Zamagni, T. Facon, M.A. Dimopoulos, X. Leleu, M. Beksac, L. Pour, R. Hajek, Z. Liu, J. Minarik, P. Moreau, J. Romejko-Jarosinska, I. Spicka, T.G. Martin, L. Qiu, C. Sachpekidis, E. Kodas, H. Van De Velde, L. Zhao, R. Orlowski, H. Goldschmidt

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  9. 9

    DP114 | ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, DEXAMETHASONE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA AND PLASMACYTOMAS: IMROZ SUBGROUP ANALYSIS by E. Zamagni, T. Facon, M.A. Dimopoulos, X. Leleu, M. Beksac, L. Pour, R. Hajek, Z. Liu, J. Minarik, P. Moreau, J. Romejko-Jarosinska, I. Spicka, V. Vorobyev, T.G. Martin, L, Qiu, C. Sachpekidis, E. Kodas, Z. Klippel, U. Khan, H. Van De Velde, R. Z. Orlowski, H. Goldschmidt

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: